156 related articles for article (PubMed ID: 33377089)
1. Assessing IL-2-Induced STAT5 Phosphorylation in Fixed, Permeabilized Foxp3
Li C; Park JH
STAR Protoc; 2020 Dec; 1(3):100195. PubMed ID: 33377089
[TBL] [Abstract][Full Text] [Related]
2. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
3. STAT5 phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity.
Goropevšek A; Gorenjak M; Gradišnik S; Dai K; Holc I; Hojs R; Krajnc I; Pahor A; Avčin T
J Leukoc Biol; 2017 Jun; 101(6):1405-1418. PubMed ID: 28254841
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
[TBL] [Abstract][Full Text] [Related]
5. New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia.
Roškar Z; Dreisinger M; Tič P; Homšak E; Bevc S; Goropevšek A
Biosensors (Basel); 2023 May; 13(5):. PubMed ID: 37232900
[TBL] [Abstract][Full Text] [Related]
6. Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets.
Ehx G; Hannon M; Beguin Y; Humblet-Baron S; Baron F
Oncotarget; 2015 Dec; 6(41):43255-66. PubMed ID: 26657728
[TBL] [Abstract][Full Text] [Related]
7. STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study.
Demaret J; Dupont G; Venet F; Friggeri A; Lepape A; Rimmelé T; Morel J; Monneret G
J Leukoc Biol; 2015 Apr; 97(4):791-6. PubMed ID: 25691382
[TBL] [Abstract][Full Text] [Related]
8. CXCL4 promoted the production of CD4
Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
[No Abstract] [Full Text] [Related]
9. Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin-2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.
Hao H; Nakayamada S; Yamagata K; Ohkubo N; Iwata S; Inoue Y; Zhang M; Zhang T; Kanda Satoh Y; Shan Y; Otsuka T; Tanaka Y
Arthritis Rheumatol; 2021 Jan; 73(1):132-142. PubMed ID: 32720470
[TBL] [Abstract][Full Text] [Related]
10. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
Wang R; Huang K
Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
[TBL] [Abstract][Full Text] [Related]
11. Decreased regulatory function of CD4
Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
[TBL] [Abstract][Full Text] [Related]
12. Age-Related Differences in Percentages of Regulatory and Effector T Lymphocytes and Their Subsets in Healthy Individuals and Characteristic STAT1/STAT5 Signalling Response in Helper T Lymphocytes.
Holcar M; Goropevšek A; Ihan A; Avčin T
J Immunol Res; 2015; 2015():352934. PubMed ID: 26525134
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Flow Cytometry Improvements in Clinical Studies.
Demaret J; Gossez M; Venet F; Monneret G
Methods Mol Biol; 2017; 1524():315-327. PubMed ID: 27815912
[TBL] [Abstract][Full Text] [Related]
14. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines.
Pesenacker AM; Bending D; Ursu S; Wu Q; Nistala K; Wedderburn LR
Blood; 2013 Apr; 121(14):2647-58. PubMed ID: 23355538
[TBL] [Abstract][Full Text] [Related]
15. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
16. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.
Simonetta F; Chiali A; Cordier C; Urrutia A; Girault I; Bloquet S; Tanchot C; Bourgeois C
Eur J Immunol; 2010 Sep; 40(9):2528-38. PubMed ID: 20690182
[TBL] [Abstract][Full Text] [Related]
17. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
Crellin NK; Garcia RV; Levings MK
J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
[TBL] [Abstract][Full Text] [Related]
19. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
20. A two-step process for thymic regulatory T cell development.
Lio CW; Hsieh CS
Immunity; 2008 Jan; 28(1):100-11. PubMed ID: 18199417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
